The US Food and Drug Administration has delayed granting full approval of Novavax’s Covid-19 vaccine despite it being on ...
The agency is sitting on a decision to grant full approval for Novavax’s shot, days after top vaccine regulator pushed out.
The delay dovetails with moves by Republican lawmakers in at least seven states to ban or limit mRNA vaccines. Some, according to KFF Health News, are also pressing regulators to revoke federal ...
Around 170 staff were cut from the FDA's Office of Inspections and Investigations this week as part of wider cuts at U.S.
More top vaccine regulators at the FDA have either left or been forced out, which could hobble the agency's ability to ...
Tracy Beth Hoeg, a sports medicine physician and epidemiologist who opposed key U.S. health policies during the COVID-19 ...
Amid a period of great upheaval at the agency, the FDA has missed its deadline to decide on approval for Novavax’s COVID-19 ...
The FDA was supposed to make a final decision about approval of Novavax's COVID-19 vaccine this week, but that deadline has ...
Public health leaders looked to UNC-Chapel Hill virologist Ralph Baric to end the pandemic. Their critics blamed it on him.
Vivex Biologics chairman John McCallum breaks down the challenges, costs, and strategies behind bringing medical innovations ...
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's ...
The delayed decision comes amid a major organizational shakeup that included the departure of top vaccine official Peter ...